Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock
Shares outstanding
151,803,139
Total 13F shares
81,041,176
Share change
+2,915,591
Total reported value
$2,492,319,624
Put/Call ratio
95%
Price per share
$30.90
Number of holders
116
Value change
+$38,889,817
Number of buys
79
Number of sells
70

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VIKING GLOBAL INVESTORS LP
13F
Company
25%
38,406,607
$1,855,039,000 30 Jun 2019
13F
Matrix Capital Management Company, LP
13F
Company
11%
17,332,191
$837,145,000 30 Jun 2019
13F
Senator Investment Group LP
13F
Company
3.4%
5,113,085
$209,918,000 30 Jun 2019
13F
BAKER BROS. ADVISORS LP
13F
Company
0.77%
1,165,411
$56,289,000 30 Jun 2019
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.59%
900,000
$43,470,000 30 Jun 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.47%
707,467
$34,171,000 30 Jun 2019
13F
BlackRock Finance, Inc.
13F
Company
0.44%
660,983
$31,925,000 30 Jun 2019
13F
BAMCO INC /NY/
13F
Company
0.43%
656,800
$31,723,000 30 Jun 2019
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.41%
625,000
$30,188,000 30 Jun 2019
13F
FMR LLC
13F
Company
0.4%
606,400
$29,289,000 30 Jun 2019
13F
Capital International Investors
13F
Company
0.4%
600,000
$28,980,000 30 Jun 2019
13F
Rock Springs Capital Management LP
13F
Company
0.4%
600,000
$28,980,000 30 Jun 2019
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.39%
591,749
$28,581,000 30 Jun 2019
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.33%
507,795
$24,526,000 30 Jun 2019
13F
TimesSquare Capital Management, LLC
13F
Company
0.3%
450,700
$21,769,000 30 Jun 2019
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.29%
438,890
$21,199,000 30 Jun 2019
13F
Redmile Group, LLC
13F
Company
0.28%
425,000
$20,528,000 30 Jun 2019
13F
Casdin Capital, LLC
13F
Company
0.31%
463,125
$20,100,347 30 Jun 2019
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.25%
375,000
$18,113,000 30 Jun 2019
13F
LOOMIS SAYLES & CO L P
13F
Company
0.22%
336,042
$16,231,000 30 Jun 2019
13F
JPMORGAN CHASE & CO
13F
Company
0.25%
380,228
$15,323,000 30 Jun 2019
13F
JENNISON ASSOCIATES LLC
13F
Company
0.19%
285,744
$13,801,000 30 Jun 2019
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.19%
285,000
$13,766,000 30 Jun 2019
13F
LORD, ABBETT & CO. LLC
13F
Company
0.17%
255,906
$12,360,000 30 Jun 2019
13F
Alyeska Investment Group, L.P.
13F
Company
0.17%
250,497
$12,099,000 30 Jun 2019
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.16%
248,900
$12,020,000 30 Jun 2019
13F
Graticule Asia Macro Advisors LLC
13F
Company
0.16%
238,791
$11,534,000 30 Jun 2019
13F
CITADEL ADVISORS LLC
13F
Company
0.15%
234,371
$11,320,000 30 Jun 2019
13F
Invesco Ltd.
13F
Company
0.15%
225,000
$10,868,000 30 Jun 2019
13F
Allianz Asset Management GmbH
13F
Company
0.13%
203,805
$9,844,000 30 Jun 2019
13F
Artal Group S.A.
13F
Company
0.13%
200,000
$9,660,000 30 Jun 2019
13F
Avoro Capital Advisors LLC
13F
Company
0.13%
200,000
$9,660,000 30 Jun 2019
13F
VANGUARD GROUP INC
13F
Company
0.13%
200,000
$9,660,000 30 Jun 2019
13F
Marshall Wace North America L.P.
13F
Company
0.13%
199,500
$9,636,000 30 Jun 2019
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.12%
177,091
$8,553,000 30 Jun 2019
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.11%
160,597
$7,756,000 30 Jun 2019
13F
FIL Ltd
13F
Company
0.1%
159,296
$7,694,000 30 Jun 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.1%
152,129
$7,348,000 30 Jun 2019
13F
MORGAN STANLEY
13F
Company
0.1%
151,087
$7,297,000 30 Jun 2019
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.1%
150,000
$7,245,000 30 Jun 2019
13F
Laurion Capital Management LP
13F
Company
0.1%
150,000
$7,245,000 30 Jun 2019
13F
Monashee Investment Management LLC
13F
Company
0.1%
145,000
$7,004,000 30 Jun 2019
13F
HIGHLINE CAPITAL MANAGEMENT, L.P.
13F
Company
0.08%
121,000
$5,844,000 30 Jun 2019
13F
HealthCor Management, L.P.
13F
Company
0.08%
120,000
$5,796,000 30 Jun 2019
13F
ORBIMED ADVISORS LLC
13F
Company
0.08%
120,000
$5,796,000 30 Jun 2019
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.08%
116,845
$5,644,000 30 Jun 2019
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.08%
115,000
$5,555,000 30 Jun 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.07%
104,799
$5,061,000 30 Jun 2019
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.07%
100,000
$4,830,000 30 Jun 2019
13F
Shellback Capital, LP
13F
Company
0.07%
100,000
$4,830,000 30 Jun 2019
13F

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q3 2019

As of 30 Sep 2019, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,041,176 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, Matrix Capital Management Company, LP, Senator Investment Group LP, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, TIGER MANAGEMENT L.L.C., TimesSquare Capital Management, LLC, FRED ALGER MANAGEMENT, LLC, and JPMORGAN CHASE & CO. This page lists 116 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
110
Q3 2019 holders
116
Holder diff
6
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 Value $ Q3 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .